Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 Apr;63(4):656–664. doi: 10.1172/JCI109348

Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.

K J Kao, S V Pizzo, P A McKee
PMCID: PMC372000  PMID: 108291

Abstract

The presence of specific Factor VIII/von Willebrand factor (FVIII/vWF) binding sites on human platelets has been demonstrated by using 125I-FVIII/vWF and washed human platelets. Binding is ristocetin-dependent and increases in proportion to the concentration of ristocetin from 0.2 to 1 mg/ml. Binding of 125I-FVIII/vWF to platelets can be competitively inhibited by unlabeled human or bovine FVIII/vWF, but not by human thrombin, fibrinogen, alpha 2-macroglobulin, equine collagen, or a lectin of Ricinus communis. Scatchard analysis of binding data indicated that the dissociation constant of FVIII/vWF receptors is 0.45--0.5 nM. There are 31,000 binding sites per platelet at 1 mg/ml of ristocetin concentration. The optimal pH range for binding is from 7.0 to 7.5. At a concentration of 2 mM, EGTA inhibits 86% of the binding; however, 20 mM of Ca++, Mg++, or EDTA have little effect. Binding sites for FVIII/vWF were found only on platelets, and no significant binding was detected with human erythrocytes or polymorphonuclear leukocytes.

Full text

PDF
656

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baugh R. F., Brown J. E., Hougie C. Preparation and platelet aggregating activity of 125I-labeled ristocetin. Anal Biochem. 1977 Mar;78(1):39–46. doi: 10.1016/0003-2697(77)90005-7. [DOI] [PubMed] [Google Scholar]
  2. Coller B. S., Franza B. R., Jr, Gralnick H. R. The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pH. Blood. 1976 May;47(5):841–854. [PubMed] [Google Scholar]
  3. Coller B. S., Gralnick H. R. Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin. J Clin Invest. 1977 Aug;60(2):302–312. doi: 10.1172/JCI108778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coller B. S. The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility. J Clin Invest. 1978 May;61(5):1168–1175. doi: 10.1172/JCI109032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. David G. S., Reisfeld R. A. Protein iodination with solid state lactoperoxidase. Biochemistry. 1974 Feb 26;13(5):1014–1021. doi: 10.1021/bi00702a028. [DOI] [PubMed] [Google Scholar]
  6. Green D., Potter E. V. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease. J Lab Clin Med. 1976 Jun;87(6):976–986. [PubMed] [Google Scholar]
  7. Greenberg J. H., Jamieson G. A. The effects of various lectins on platelet aggregation and release. Biochim Biophys Acta. 1974 Apr 29;345(2):231–242. doi: 10.1016/0005-2736(74)90261-2. [DOI] [PubMed] [Google Scholar]
  8. Hovig T., Stormorken H. Ultrastructural studies on the platelet plug formation in bleeding time wounds from normal individuals and patients with von Willebrand's disease. Acta Pathol Microbiol Scand Suppl. 1974;Suppl 248:105–122. [PubMed] [Google Scholar]
  9. Howard M. A. Inhibition and reversal of ristocetin - induced platelet aggregation. Thromb Res. 1975 Jun;6(6):489–499. doi: 10.1016/0049-3848(75)90061-4. [DOI] [PubMed] [Google Scholar]
  10. Howard M. A., Sawers R. J., Firkin B. G. Ristocetin: a means of differentiating von Willebrand's disease into two groups. Blood. 1973 May;41(5):687–690. [PubMed] [Google Scholar]
  11. Jenkins C. S., Phillips D. R., Clemetson K. J., Meyer D., Larrieu M. J., Lüscher E. F. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease. J Clin Invest. 1976 Jan;57(1):112–124. doi: 10.1172/JCI108251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kinlough-Rathbone R. L., Mustard J. F., Packham M. A., Perry D. W., Reimers H. J., Cazenave J. P. Properties of washed human platelets. Thromb Haemost. 1977 Apr 30;37(2):291–308. [PubMed] [Google Scholar]
  13. Kirby E. P., Mills D. C. The interaction of bovine factor VIII with human platelets. J Clin Invest. 1975 Aug;56(2):491–502. doi: 10.1172/JCI108116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. Legaz M. E., Schmer G., Counts R. B., Davie E. W. Isolation and characterization of human Factor VIII (antihemophilic factor). J Biol Chem. 1973 Jun 10;248(11):3946–3955. [PubMed] [Google Scholar]
  16. NIH conference. Factor VIII. Ann Intern Med. 1977 May;86(5):598–616. [PubMed] [Google Scholar]
  17. Nachman R. L., Jaffe E. A. Subcellular platelet factor VIII antigen and von Willebrand factor. J Exp Med. 1975 May 1;141(5):1101–1113. doi: 10.1084/jem.141.5.1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nachman R. L., Jaffe E. A., Weksler B. B. Immunoinhibition of ristocetin-induced platelet aggregation. J Clin Invest. 1977 Jan;59(1):143–148. doi: 10.1172/JCI108612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Okumura T., Hasitz M., Jamieson G. A. Platelet glycocalicin. Interaction with thrombin and role as thrombin receptor of the platelet surface. J Biol Chem. 1978 May 25;253(10):3435–3443. [PubMed] [Google Scholar]
  20. Okumura T., Jamieson G. A. Platelet glycocalicin. I. Orientation of glycoproteins of the human platelet surface. J Biol Chem. 1976 Oct 10;251(19):5944–5949. [PubMed] [Google Scholar]
  21. Okumura T., Jamieson G. A. Platelet glycocalicin: a single receptor for platelet aggregation induced by thrombin or ristocetin. Thromb Res. 1976 May;8(5):701–706. doi: 10.1016/0049-3848(76)90250-4. [DOI] [PubMed] [Google Scholar]
  22. Phillips D. R. Effect of trypsin on the exposed polypeptides and glycoproteins in the human platelet membrane. Biochemistry. 1972 Nov 21;11(24):4582–4588. doi: 10.1021/bi00774a025. [DOI] [PubMed] [Google Scholar]
  23. Shapiro G. A., Andersen J. C., Pizzo S. V., McKee P. A. The subunit structure of normal and hemophilic factor VIII. J Clin Invest. 1973 Sep;52(9):2198–2210. doi: 10.1172/JCI107405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shiu R. P., Friesen H. G. Properties of a prolactin receptor from the rabbit mammary gland. Biochem J. 1974 May;140(2):301–311. doi: 10.1042/bj1400301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sodetz J. M., Pizzo S. V., McKee P. A. Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. J Biol Chem. 1977 Aug 10;252(15):5538–5546. [PubMed] [Google Scholar]
  26. Switzer M. E., McKee P. A. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure. J Clin Invest. 1976 Apr;57(4):925–937. doi: 10.1172/JCI108369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]
  28. Weiss H. J., Rogers J., Brand H. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. J Clin Invest. 1973 Nov;52(11):2697–2707. doi: 10.1172/JCI107464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Williams L. T., Lefkowitz R. J. Slowly reversible binding of catecholamine to a nucleotide-sensitive state of the beta-adrenergic receptor. J Biol Chem. 1977 Oct 25;252(20):7207–7213. [PubMed] [Google Scholar]
  30. Zucker M. B., Kim S. J., McPherson J., Grant R. A. Binding of factor VIII to platelets in the presence of ristocetin. Br J Haematol. 1977 Apr;35(4):535–549. doi: 10.1111/j.1365-2141.1977.tb00619.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES